202 related articles for article (PubMed ID: 10097041)
41. G4941K substitution in the pore-lining S6 helix of the skeletal muscle ryanodine receptor increases RyR1 sensitivity to cytosolic and luminal Ca
Xu L; Mowrey DD; Chirasani VR; Wang Y; Pasek DA; Dokholyan NV; Meissner G
J Biol Chem; 2018 Feb; 293(6):2015-2028. PubMed ID: 29255089
[TBL] [Abstract][Full Text] [Related]
42. Identification of a two EF-hand Ca2+ binding domain in lobster skeletal muscle ryanodine receptor/Ca2+ release channel.
Xiong H; Feng X; Gao L; Xu L; Pasek DA; Seok JH; Meissner G
Biochemistry; 1998 Apr; 37(14):4804-14. PubMed ID: 9537997
[TBL] [Abstract][Full Text] [Related]
43. An Exciting Couple.
Etlinger JD
J Pediatr Ophthalmol Strabismus; 2018 May; 55(3):149-150. PubMed ID: 29796677
[No Abstract] [Full Text] [Related]
44. A negatively charged region of the skeletal muscle ryanodine receptor is involved in Ca(2+)-dependent regulation of the Ca(2+) release channel.
Hayek SM; Zhao J; Bhat M; Xu X; Nagaraj R; Pan Z; Takeshima H; Ma J
FEBS Lett; 1999 Nov; 461(3):157-64. PubMed ID: 10567689
[TBL] [Abstract][Full Text] [Related]
45. Novel skeletal muscle ryanodine receptor mutation in a large Brazilian family with malignant hyperthermia.
McWilliams S; Nelson T; Sudo RT; Zapata-Sudo G; Batti M; Sambuughin N
Clin Genet; 2002 Jul; 62(1):80-3. PubMed ID: 12123492
[TBL] [Abstract][Full Text] [Related]
46. Stressed out: the skeletal muscle ryanodine receptor as a target of stress.
Bellinger AM; Mongillo M; Marks AR
J Clin Invest; 2008 Feb; 118(2):445-53. PubMed ID: 18246195
[TBL] [Abstract][Full Text] [Related]
47. Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.
Amador FJ; Kimlicka L; Stathopulos PB; Gasmi-Seabrook GM; Maclennan DH; Van Petegem F; Ikura M
J Mol Biol; 2013 Nov; 425(21):4034-46. PubMed ID: 23978697
[TBL] [Abstract][Full Text] [Related]
48. An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.
Karunasekara Y; Rebbeck RT; Weaver LM; Board PG; Dulhunty AF; Casarotto MG
FASEB J; 2012 Dec; 26(12):5049-59. PubMed ID: 22962299
[TBL] [Abstract][Full Text] [Related]
49. Channel Gating Dependence on Pore Lining Helix Glycine Residues in Skeletal Muscle Ryanodine Receptor.
Mei Y; Xu L; Mowrey DD; Mendez Giraldez R; Wang Y; Pasek DA; Dokholyan NV; Meissner G
J Biol Chem; 2015 Jul; 290(28):17535-45. PubMed ID: 25998124
[TBL] [Abstract][Full Text] [Related]
50. Functional defects in six ryanodine receptor isoform-1 (RyR1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling.
Yang T; Ta TA; Pessah IN; Allen PD
J Biol Chem; 2003 Jul; 278(28):25722-30. PubMed ID: 12732639
[TBL] [Abstract][Full Text] [Related]
51. Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients.
Oyamada H; Oguchi K; Saitoh N; Yamazawa T; Hirose K; Kawana Y; Wakatsuki K; Oguchi K; Tagami M; Hanaoka K; Endo M; Iino M
Jpn J Pharmacol; 2002 Feb; 88(2):159-66. PubMed ID: 11928716
[TBL] [Abstract][Full Text] [Related]
52. Single-amino-acid deletion in the RYR1 gene, associated with malignant hyperthermia susceptibility and unusual contraction phenotype.
Sambuughin N; McWilliams S; de Bantel A; Sivakumar K; Nelson TE
Am J Hum Genet; 2001 Jul; 69(1):204-8. PubMed ID: 11389482
[TBL] [Abstract][Full Text] [Related]
53. Novel mutation in the RYR1 gene (R2454C) in a patient with malignant hyperthermia.
Gencik M; Gencik A; Mortier W; Epplen JT
Hum Mutat; 2000 Jan; 15(1):122. PubMed ID: 10612851
[No Abstract] [Full Text] [Related]
54. Skeletal muscle ryanodine receptor mutations associated with malignant hyperthermia showed enhanced intensity and sensitivity to triggering drugs when expressed in human embryonic kidney cells.
Sato K; Roesl C; Pollock N; Stowell KM
Anesthesiology; 2013 Jul; 119(1):111-8. PubMed ID: 23459219
[TBL] [Abstract][Full Text] [Related]
55. The pore structure of the closed RyR1 channel.
Ludtke SJ; Serysheva II; Hamilton SL; Chiu W
Structure; 2005 Aug; 13(8):1203-11. PubMed ID: 16084392
[TBL] [Abstract][Full Text] [Related]
56. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
[TBL] [Abstract][Full Text] [Related]
57. A 37-amino acid sequence in the skeletal muscle ryanodine receptor interacts with the cytoplasmic loop between domains II and III in the skeletal muscle dihydropyridine receptor.
Leong P; MacLennan DH
J Biol Chem; 1998 Apr; 273(14):7791-4. PubMed ID: 9525869
[TBL] [Abstract][Full Text] [Related]
58. Skeletal muscle type ryanodine receptor is involved in calcium signaling in human B lymphocytes.
Sei Y; Gallagher KL; Basile AS
J Biol Chem; 1999 Feb; 274(9):5995-6002. PubMed ID: 10026226
[TBL] [Abstract][Full Text] [Related]
59. Ryanodine receptor type 3 (RYR3) as a novel gene associated with a myopathy with nemaline bodies.
Nilipour Y; Nafissi S; Tjust AE; Ravenscroft G; Hossein Nejad Nedai H; Taylor RL; Varasteh V; Pedrosa Domellöf F; Zangi M; Tonekaboni SH; Olivé M; Kiiski K; Sagath L; Davis MR; Laing NG; Tajsharghi H
Eur J Neurol; 2018 Jun; 25(6):841-847. PubMed ID: 29498452
[TBL] [Abstract][Full Text] [Related]
60. Malignant hyperthermia mutation sites in the Leu2442-Pro2477 (DP4) region of RyR1 (ryanodine receptor 1) are clustered in a structurally and functionally definable area.
Bannister ML; Hamada T; Murayama T; Harvey PJ; Casarotto MG; Dulhunty AF; Ikemoto N
Biochem J; 2007 Jan; 401(1):333-9. PubMed ID: 16958617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
